mp.weixin.qq.com·· 6 hours agoPickScore63
China NMPA Approves Jiaxi Holdings' Batoclimab Injection for AChR-Antibody-Positive Adult gMG
In brief
On October 22, China's National Medical Products Administration approved batoclimab injection, brand name Enlida, filed by Jiaxi Holdings. The drug is approved for use in combination with conventional therapy to treat adult patients with generalized myasthenia gravis (gMG) who are positive for AChR antibodies.
Why it matters
The brief states the approved indication, combination with conventional therapy, and the AChR-antibody-positive adult restriction, clarifying the eligible population.
Source: mp.weixin.qq.com · mp.weixin.qq.com